Navigation Links
Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
Date:12/2/2008

CHENGDU, China, Dec. 2 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE EuroNext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced the implementation of a new sales and marketing strategy to categorize both distributors and hospital clients into three classes in order to optimize their sales and marketing structure.

The new strategy has classified distributors into three classes to optimize the clients from various distribution channels. The target goal is to develop 10 Class A nation-wide distributors with over $73.5 million annual sales, each which will contribute approximately 30% of Tianyin's annual sales, and 100 Class B distributors with annual sales between $29.4 million and $73.5 million each, which will contribute approximately 40% of annual sales. Class C distributors which have annual sales above $7 million and below $29.4 million, will be supplementary to class A and B clients and contribute approximately 30% of annual sales. The Company anticipates that this strategy will improve long-term relationships with strategic distribution partners, while optimizing and further diversifying the customer base.

The management also categorized hospital clients into three classes. Class A hospitals are university hospitals with superior reputations which have over $1.5 million of monthly medicine consumption; Class B hospitals have total monthly medicine consumption between $1 million and $1.5 million, while Class C hospitals have total monthly medicine consumption between $0.5 million and $1 million. The sales team will mainly focus and spend most of their efforts on Class A and Class B hospitals to generate major sales, but will dedicate some time to Class C hospitals. The Company expects that sales from Class B and Class C hospitals could be favorably promoted by the relations established with major Class A hos
'/>"/>

SOURCE Tianyin Pharmaceutical, Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
2. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
3. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
4. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
5. Tianyin Pharmaceutical Appoints Three New Independent Board Members
6. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
7. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
8. Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film
9. Cerimon Pharmaceuticals Appoints James S. Shannon, M.D., to Board of Directors
10. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- N...mp; Trademark Office (PTO) has allowed the patent ... NOD technology. , NOD technology is a hi...,proteins into bio-adhesive nano-particles to enab...s injections. NOD technology is a platform technol...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ --... & Drug Administration (SFDA) has approved the...s oral insulin project,(Nodlin), an innovative ins...val allows Biolaxy to initiate its first phase I c...haracteristic of high blood glucose and poor,metab...
(Date:11/24/2009)... The FBI recently approved the Pro...s participating in or generating DNA records for t... Madison, WI USA (PRWEB) -- The FBI recently... for use by laboratories participating in, or gen...stem (NDIS). NDIS currently contains more than sev...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRNe...TL), formerly Calotto Capital Inc., a leading prov... the stem cell research and fertility clinic marke...ts for the third quarter ended September 30, 2009....1.46 million compared with $1.43 million in Q3 200...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10
... Embla Systems, a leader in the field of,sleep di...e signing of an,exclusive agreement with the Beth ...stribution of the Cardio Pulmonary Coupling (CPC) ...ldberger, C-K. Peng, and Mr. Joseph,Mietus., CPC ...can be,visualized, by presenting a simple and accu...
...resented at San Antonio Breast Cancer Symposium, ...,leader in the rapidly evolving field of molecular...international consortium has demonstrated the,prog...ognosis test in,patients who have 1-3 positive lym...urately identify a low risk group of lymph,node-po...
...., Dec. 13 Masada Resource Group, LLC, a,Birmingh...aste-to-ethanol,technology, announced today that i...quipment the company recently purchased from the T...Auburn, Alabama. Last March,Masada was chosen as t...nt,facilities and equipment in Muscle Shoals, Alab...
Other Biology Technology:Embla Systems in Collaboration with Beth Israel Deaconess Medical Center to Develop Cardio-Pulmonary Coupling Technology 2MammaPrint(R) Breast Cancer Test Validated in Lymph Node-Positive Breast Cancer Patients 2MammaPrint(R) Breast Cancer Test Validated in Lymph Node-Positive Breast Cancer Patients 3Masada Resource Group Donates TVA Biomass Pilot Plant Facilities and Equipment to Auburn University 2
(Date:11/26/2009)...s are some of the Ocean,s most distinctive residen...is strange head shape, says Michelle McComb from ...s the shark,s vision. ,Perhaps their visual field ... McComb, giving the sharks excellent stereovision ..., there were two schools of thought on this theory...
(Date:11/26/2009)... impressive antlers, red deer have been caught in ...antlers are much more than decorative. They are le...ng. John Currey, from The University of York, UK, ... bone for over half a century and has become fasci...gh a long-standing collaboration with Tomas Landet...
(Date:11/26/2009)...at last worked out a way of using recordings of bi...lations. This is the first time sound recordings f...ccurate estimates of bird species, populations. Be...cological Society,s Journal of Applied Ecology , ... major advance in our ability to monitor whale and...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2Tough yet stiff deer antler is materials scientist's dream 2Ecologists sound out new solution for monitoring cryptic species 2Cold Laser Technology Made Even More Accessible with Powerful New Product Available from Laser Therapy US 52725 1Cold Laser Technology Made Even More Accessible with Powerful New Product Available from Laser Therapy US 52725 2Reprints Desk Makes Pharmaceutical ePrint Procurement Service Available Through FIZ AutoDoc Document Delivery System 52723 1Reprints Desk Makes Pharmaceutical ePrint Procurement Service Available Through FIZ AutoDoc Document Delivery System 52723 2Reprints Desk Makes Pharmaceutical ePrint Procurement Service Available Through FIZ AutoDoc Document Delivery System 52723 3Leading health organizations launch new accreditation process for laboratories across Africa 52721 1Leading health organizations launch new accreditation process for laboratories across Africa 52721 2Leading health organizations launch new accreditation process for laboratories across Africa 52721 3Leading health organizations launch new accreditation process for laboratories across Africa 52721 4
...sts have discovered that a dominant hyena puts her...by passing on high levels of certain hormones that...d sexually advanced. , The report, published in th...mammals to demonstrate a relationship between a fe...r offspring,s behavior through prenatal hormone tr...
... that can harm the brain immediately after a strok... to new research. Insights from the study could ch...ow for effective treatment from a couple of hours ...ideas for drug development. , Working with rats, ... of Radiology and Neurology found that the enzyme ...
...ystematic review highlights strong results from a ... worldwide use of the low-cost drug Bactrim to hel...eviewers surveyed medical literature on the preven...for the generic medicine cotrimoxazole -- for chil...dly to a person whose immune system is weakened by...
Other Biology News:'Bad' enzymes may wear white hats after stroke 2'Bad' enzymes may wear white hats after stroke 3'Bad' enzymes may wear white hats after stroke 4Low-cost drug gaining favor for use in HIV-infected children in poor countries 2
... ABsolute QPCR SYBR Green Mixes are optimised for ... necessary to perform Quantitative PCR, with the e... Green Mix contains optimal levels of active SYBR ...ed in a proprietary reaction buffer that enables d...
... The Vibratome Roto-Shake Genie is an all-in-one r...rforms five different mixing motions: rotating, r...and rotating/rolling, as well as a combination of ...g portion of the Vibraotme Roto-Shake Genie consis...
... Roches RTS AviTag E. coli Biotinylation Kit, Plas...d 500 E. coli expression kits. (Cat. No. 3 186 148... for the easy introduction of a C- or N-terminal A...be enzymatically mono-biotinylated by E. coli biot...
... Product Mouse monoclonal [1320] to RFC1 Immuno...subunit of human Replication Factor C expressed in...with Human and S. cerevisiae. Not yet tested in ot...nit of RFC1 Background Information Replication ...
Biology Products: